The Potential Role of Circular Rnas -Regulated Pi3k Signaling in Non-Small Cell Lung Cancer: Molecular Insights and Clinical Perspective Publisher Pubmed



Kahkesh S¹ ; Khoshnazar SM² ; Gholinezhad Y³ ; Esmailzadeh S⁴ ; Hosseini SA⁵ ; Alimohammadi M⁶ ; Mafi A^{7, 8}
Source: Pathology Research and Practice Published:2024

Abstract

Non-small cell lung cancer (NSCLC), accounting for more than 80% of all cases, is the predominant form of lung cancer and the leading cause of cancer-related deaths worldwide. Significant progress has been made in diagnostic techniques, surgical interventions, chemotherapy protocols, and targeted therapies at the molecular level, leading to enhanced treatment outcomes in patients with NSCLC. Extensive evidence supports the use of circular RNAs (circRNAs), a specific category of naturally occurring non-coding small RNAs (ncRNAs), for the diagnosis, monitoring of treatment efficacy, and assessment of survival in NSCLC. CircRNAs have been identified to play significant roles in various aspects of cancer formation, either as tumor suppressors or tumor promoters, contributing to cancer development through several signaling pathways, including the phosphoinositide 3-kinases (PI3Ks) pathway. This pathway is well-established because of its regulatory role in essential cellular processes. CircRNAs regulate the PI3K/AKT pathway by targeting diverse cellular elements. This review aims to provide insight into the involvement of several circRNAs linked to the PI3K/AKT pathway in NSCLC. © 2024 Elsevier GmbH